Literature DB >> 19318514

Lipoprotein lipase: from gene to obesity.

Hong Wang1, Robert H Eckel.   

Abstract

Lipoprotein lipase (LPL) is a multifunctional enzyme produced by many tissues, including adipose tissue, cardiac and skeletal muscle, islets, and macrophages. LPL is the rate-limiting enzyme for the hydrolysis of the triglyceride (TG) core of circulating TG-rich lipoproteins, chylomicrons, and very low-density lipoproteins (VLDL). LPL-catalyzed reaction products, fatty acids, and monoacylglycerol are in part taken up by the tissues locally and processed differentially; e.g., they are stored as neutral lipids in adipose tissue, oxidized, or stored in skeletal and cardiac muscle or as cholesteryl ester and TG in macrophages. LPL is regulated at transcriptional, posttranscriptional, and posttranslational levels in a tissue-specific manner. Nutrient states and hormonal levels all have divergent effects on the regulation of LPL, and a variety of proteins that interact with LPL to regulate its tissue-specific activity have also been identified. To examine this divergent regulation further, transgenic and knockout murine models of tissue-specific LPL expression have been developed. Mice with overexpression of LPL in skeletal muscle accumulate TG in muscle, develop insulin resistance, are protected from excessive weight gain, and increase their metabolic rate in the cold. Mice with LPL deletion in skeletal muscle have reduced TG accumulation and increased insulin action on glucose transport in muscle. Ultimately, this leads to increased lipid partitioning to other tissues, insulin resistance, and obesity. Mice with LPL deletion in the heart develop hypertriglyceridemia and cardiac dysfunction. The fact that the heart depends increasingly on glucose implies that free fatty acids are not a sufficient fuel for optimal cardiac function. Overall, LPL is a fascinating enzyme that contributes in a pronounced way to normal lipoprotein metabolism, tissue-specific substrate delivery and utilization, and the many aspects of obesity and other metabolic disorders that relate to energy balance, insulin action, and body weight regulation.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19318514     DOI: 10.1152/ajpendo.90920.2008

Source DB:  PubMed          Journal:  Am J Physiol Endocrinol Metab        ISSN: 0193-1849            Impact factor:   4.310


  263 in total

1.  Determination of lipoprotein lipase activity using a novel fluorescent lipase assay.

Authors:  Debapriya Basu; Jahan Manjur; Weijun Jin
Journal:  J Lipid Res       Date:  2011-01-26       Impact factor: 5.922

2.  Mutations in lipoprotein lipase that block binding to the endothelial cell transporter GPIHBP1.

Authors:  Constance V Voss; Brandon S J Davies; Shelly Tat; Peter Gin; Loren G Fong; Christopher Pelletier; Charlene D Mottler; André Bensadoun; Anne P Beigneux; Stephen G Young
Journal:  Proc Natl Acad Sci U S A       Date:  2011-04-25       Impact factor: 11.205

3.  Fatty acids bind tightly to the N-terminal domain of angiopoietin-like protein 4 and modulate its interaction with lipoprotein lipase.

Authors:  Terje Robal; Mikael Larsson; Miina Martin; Gunilla Olivecrona; Aivar Lookene
Journal:  J Biol Chem       Date:  2012-07-07       Impact factor: 5.157

4.  Novel GPIHBP1-independent pathway for clearance of plasma TGs in Angptl4-/-Gpihbp1-/- mice.

Authors:  Emily M Cushing; Kelli L Sylvers; Xun Chi; Shwetha K Shetty; Brandon S J Davies
Journal:  J Lipid Res       Date:  2018-05-08       Impact factor: 5.922

5.  Effect of chronic intermittent hypoxia on triglyceride uptake in different tissues.

Authors:  Qiaoling Yao; Mi-Kyung Shin; Jonathan C Jun; Karen L Hernandez; Neil R Aggarwal; Jason R Mock; Jason Gay; Luciano F Drager; Vsevolod Y Polotsky
Journal:  J Lipid Res       Date:  2013-02-05       Impact factor: 5.922

Review 6.  Implications of Lipids in Neonatal Body Weight and Fat Mass in Gestational Diabetic Mothers and Non-Diabetic Controls.

Authors:  Emilio Herrera; Henar Ortega-Senovilla
Journal:  Curr Diab Rep       Date:  2018-02-05       Impact factor: 4.810

7.  Chronic intermittent hypoxia induces atherosclerosis via activation of adipose angiopoietin-like 4.

Authors:  Luciano F Drager; Qiaoling Yao; Karen L Hernandez; Mi-Kyung Shin; Shannon Bevans-Fonti; Jason Gay; Thomas E Sussan; Jonathan C Jun; Allen C Myers; Gunilla Olivecrona; Alan R Schwartz; Nils Halberg; Philipp E Scherer; Gregg L Semenza; David R Powell; Vsevolod Y Polotsky
Journal:  Am J Respir Crit Care Med       Date:  2013-07-15       Impact factor: 21.405

8.  Measurement of long-chain fatty acid uptake into adipocytes.

Authors:  Elena Dubikovskaya; Rostislav Chudnovskiy; Grigory Karateev; Hyo Min Park; Andreas Stahl
Journal:  Methods Enzymol       Date:  2014       Impact factor: 1.600

9.  Mice lacking ANGPTL8 (Betatrophin) manifest disrupted triglyceride metabolism without impaired glucose homeostasis.

Authors:  Yan Wang; Fabiana Quagliarini; Viktoria Gusarova; Jesper Gromada; David M Valenzuela; Jonathan C Cohen; Helen H Hobbs
Journal:  Proc Natl Acad Sci U S A       Date:  2013-09-16       Impact factor: 11.205

10.  Triglyceride metabolism in bone tissue is associated with osteoblast and osteoclast differentiation: a gene expression study.

Authors:  Jana Dragojevič; Janja Zupan; Gregor Haring; Simon Herman; Radko Komadina; Janja Marc
Journal:  J Bone Miner Metab       Date:  2013-04-16       Impact factor: 2.626

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.